chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ACUTE SINUS HEADACHE; SINUS PRESSURE ON BRIDGE OF NOSE/EARS; LOUD RINGING ON BILATERAL EARS; This spontaneous report received from a patient concerned a 42 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No pertinent medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 23-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-JUL-2021, the patient experienced acute sinus headache. On 26-JUL-2021, the patient experienced sinus pressure on bridge of nose/ears. On 26-JUL-2021, the patient experienced loud ringing on bilateral ears. On AUG-2021, treatment medications included: alprazolam, and prednisone. On 04-AUG-2021, Laboratory data included: SARS-CoV-2 RT-PCR test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from loud ringing on bilateral ears, and had not recovered from acute sinus headache, and sinus pressure on bridge of nose/ears. This report was non-serious.
Vaccinee was given a series of 3 Engerix-B vaccinations on 5DEC89 lot not 585A4, 2JAN90 lot no. 586A4, & 31MAY90 lot no 587A4; Serology testing on 29AUG90 showed that vaccinee failed to seroconvert.
pt had a positive COVID test on 6/7/22; in local Hospice for dementia, agitation; pt passed away of dementia, complicated by recent COVID infection in the hospice facility
Child presented with moderate hives. Finished 5 day course Flagyl 8/13. Required steroid & loratidine.  ER visit 8/16 to boost steroid dose.  Seen again about 1 week later and steroid stopped, kept on Claritin only rest of month.
The patient developed an itchy rash on the back which then extended to their arms. This began to occur approximately 5 hours after receiving the injection.  The patient took Benadryl at night. The rash was resolved by the next morning. They took one more Benadryl for some residual itching which resolved after doing so.
Fever, extreme irritability, pain at injection site, night sweats, nightmares, dark circles under eyes, immediately following vaccine and for several days. In the past year since this vaccine, she has had behavioral problems that are markedly more severe than preceding the vaccine. These are ongoing.
HA W/I 24 hrs. Fever W/I 24 hrs. Muscle pain W/I 24 hrs. Red ring 3 days after.
Side effects that I had after the first shot; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects that I had after the first shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On an unknown date, the patient experienced ADVERSE EVENT (Side effects that I had after the first shot).   At the time of the report, ADVERSE EVENT (Side effects that I had after the first shot) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Developed midsternal chest pain and intermittent SOB on 11/16/2021. Seen at Urgent care x 2, Seen at medical center on 11/21/21 for continued symptoms
sluggish; wanted to sleep a lot; like he had something, like the flu; felt knocked down for a day or 2 meaning tired; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (sluggish), SOMNOLENCE (wanted to sleep a lot), INFLUENZA LIKE ILLNESS (like he had something, like the flu) and FATIGUE (felt knocked down for a day or 2 meaning tired) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SLUGGISHNESS (sluggish), SOMNOLENCE (wanted to sleep a lot), INFLUENZA LIKE ILLNESS (like he had something, like the flu) and FATIGUE (felt knocked down for a day or 2 meaning tired). At the time of the report, SLUGGISHNESS (sluggish), SOMNOLENCE (wanted to sleep a lot), INFLUENZA LIKE ILLNESS (like he had something, like the flu) and FATIGUE (felt knocked down for a day or 2 meaning tired) outcome was unknown.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
The day following the immunization the patient experienced muscle weakness and fatigue to the extent that it was difficult to move. The patient reports improvement on the 2nd day after immunization but still experiencing muscle weakness and fatigue
Started with L hip joint pain, moved down to leg muscle pain in both legs, took Aleve and then 1130pm started chilling and rigoring, this continued for approx. 4 hours of severe rigors. Temp reached 102.6, muscle and joint pain became more severe and was awake for most of the night, with the rigors and fever increasing noted that pulse and Resp rate were increased during this time.
From 10PM (approx 9 hrs post 2nd injection), symptoms included fever and severe chills and joint pain; slight dizziness; vomit x1 at 6AM the next morning; symptoms subsided by approx 24 hrs post injection. Minor weakness and overall malaise continued for approx 48 hrs total.
01/02/23 presents to ED for "fever". PMHx of "HIV/AIDS, hx of syphillis, Hep B chronic infection"
Breathing became very difficult; Blood pressure was really high; Heart rate was off the charts; Face numb; Tongue numb; Throat numb; Lips numb; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Breathing became very difficult), BLOOD PRESSURE INCREASED (Blood pressure was really high), HEART RATE INCREASED (Heart rate was off the charts), HYPOAESTHESIA (Face numb) and HYPOAESTHESIA ORAL (Tongue numb) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DYSPNOEA (Breathing became very difficult), BLOOD PRESSURE INCREASED (Blood pressure was really high), HEART RATE INCREASED (Heart rate was off the charts), HYPOAESTHESIA (Face numb), HYPOAESTHESIA ORAL (Tongue numb), PHARYNGEAL HYPOAESTHESIA (Throat numb) and HYPOAESTHESIA ORAL (Lips numb). The patient was treated with EPINEPHRINE at a dose of 1 dosage form. At the time of the report, DYSPNOEA (Breathing became very difficult), BLOOD PRESSURE INCREASED (Blood pressure was really high), HEART RATE INCREASED (Heart rate was off the charts), HYPOAESTHESIA (Face numb), HYPOAESTHESIA ORAL (Tongue numb), PHARYNGEAL HYPOAESTHESIA (Throat numb) and HYPOAESTHESIA ORAL (Lips numb) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Relevant concomitant medications were reported.
Bump formed at the site of first shot (left arm); This is a spontaneous report from a contactable consumer, the patient. A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN,) dose 1 via an unspecified route of administration in the left arm on 10Mar2021 (at the age of 52-years-old) as a dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On unknown date in 2021, the patient experienced bump formed at the site (left arm). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 01Apr2021, the patient underwent the lab test covid-19, and the result was negative. The patient did not receive any treatment for the events. The clinical outcome of the event bump formed at the site (left arm) was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Received vaccine on 12/3.  Developed T to 100-101 with emesis, nausea, diarrhea.  Fever X2D, diarrhea X3D.  Still with nausea, diarrhea, general feeling of fatigue & weakness.  Neurol normal.
Patient began feeling short of breath on 9/20/21 in the evening. Patient also reports cough. Patient has a new oxygen requirement of 2L. Patient is COVID-19 positive and will be receiving dexamethasone. Patient will be admitted to the hospital.
1st Pfizer vaccination on 3-29-21. 3-31-21 patient developed fatigue since 3/31/21. 4-4-21 lymph nodes in L axillary and mod size. approx 1 inch, seen in (withheld).
Itchy mosquito bite looking bump that developed into red itchy spot about 1.5 in diameter.  Stopped itching for a couple of days then came back. Still red and itchy.
Received Vaccination Tuesday 12/29 and symptoms began Tuesday 1/5. 1/5 began experiencing pain at the injection site and later in the night noticed redness and a hardened bump at the site. While trying to sleep I noticed pain had traveled toward the clavicle area where a swollen lymph node was noticed not sure if related.
1 week post injection patient began having pain and pressure identical to previous symptoms of endometriosis. Prior to vaccination, patient had no endometriosis symptoms for ~20 years. Symptoms have, and continue to increase in severity and patient is now seeking treatment from Dr. (appointment scheduled for 5/28/2021, the earliest available appointment).
Fever 101 degrees. Rash on stomach, chest, in elbows & knee joints. Sx onset 1-29-11.
INJECTION SITE HOT TO TOUCH; INJECTION SITE KNOT; EXPIRED VACCINE USED; INJECTION SITE SORENESS/PAIN; This spontaneous report received from a patient concerned a 72 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 043A21A expiry: 10-JUL-2021) dose was not reported, administered on 10-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-JUL-2021, the subject experienced injection site hot to touch. On 10-JUL-2021, the subject experienced injection site knot. On 10-JUL-2021, the subject experienced expired vaccine used. On 10-JUL-2021, the subject experienced injection site soreness/pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the injection site hot to touch, injection site knot, injection site soreness/pain and expired vaccine used was not reported. This report was non-serious.
Myalgia, Fever, NauseaVomiting, body chills, fatigue Narrative:  Other Relevant History:
I had a migraine, and it wouldn't go away. I've had migraines before but they never lasted this long. It was in the left side of my head, the same as the injections. My Imitrex Tylenol wouldn't help remove. My armpit was swollen. They gave me a shot of Toradol, and a prescription for Fioricet
Pt. states that after receiving the 1st of Moderna 07/19/2021, started experiencing symptoms 07/20/2021 of headaches, flu-like symptoms, nausea, chills. Left with strong headaches and nausea, Primary visit 07/27/2021 no recommendations. Re-visit in 30 days plans.
Pt feeling faint & nauseated after vaccination.  Went to Oberservation area to lie down, vomited. After resting began to walk around.  Pt left in stable condition.
got covid three times and was hospital twice; got covid three times and was hospital twice; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  An elderly female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (caused and prolonged hospitalization, medically significant), SUSPECTED COVID-19 (caused and prolonged hospitalization, medically significant), outcome "unknown" and all described as "got covid three times and was hospital twice".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300073218 Same patient/event; different dose;
pain/ uppper body is very sensitive, sore; skin that is sensitive to touch; blotches on the back and chest; general feeling of tiredness; Headache; muscle aches; Red rash; uncomfortable; This is a spontaneous report from a contactable consumer (patient).  A 79-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248, expiration date unknown), via an unspecified route of administration on 14Jan2021 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On 15Jan2021, the patient experienced pain/ upper body is very sensitive, sore, headache, skin that is sensitive to touch, blotches on the back and chest, general feeling of tiredness. On an unspecified dates in Jan2021, the patient experienced muscle aches, red rash, and uncomfortable. The patient reported that he did not have any symptoms of the COVID when he got the vaccine shot. He mentioned that he made an appointment to get a test. The outcome of the events skin that is sensitive to touch, muscle aches, red rash was not recovered; while the outcome of the rest of the events was unknown.
Patient received immunizations on 10/08/2003.  On 10/21/2003, patient began to experience hair loss (about 40 to 50 strands of hair) everytime she brushed her hair.  No other symptoms were reported.  Around 10/30/2003, patient reported a significant improvement on condition.  Patient called to report condition on 10/31/2003.
On 4-12-13 pt. went to Ugent Care diagnosed with cellulitis, abscess at inj. site and her arm is swollen past elbow will follow up with her MD. Also pt. reported numbness in fingers.
Headache; 24 hours later swollen lymph nodes and swelling on left side (injection side) of the body.  This has not subsided as of 9am on 4/21/2021.  Neck is swollen and sore, lymph nodes are extremely sore and sensitive from ear to below breast. Scheduled for an ultrasound next week.
Intense pain felt in arm shot was given almost right away.  Several hours later felt numbness from shoulder to wrist, like it was asleep, lasted for 2 days.  Intese pain in from middle of back through shoulder down to middle of forearm followed.  This pain lasted approximately 2 weeks.  Pain was so intense in prevented good sleep.
4 days after FLUVIRIN vaccine notice bump ? chickenpox on lower leg (2), trunk (cluster of 3), and arm, very itchy, no temperature - lesion went away in a day.
Whole arm swells at night and extreme pain every night now I have not been able to sleep longer than 4 hours a night since because I'm up every hour in pain and hands swell on same side as vaccine
Shingles with severe pain and rash, took acyclovir and oxy for pain.  I was bedridden for 2 1/2 weeks with pain,.  Still having pain at the end of 4 weeks.
Intense Nerve burning and full body pain; general muscle weakness, sleeplessness, digestive track sluggishness and inflammation. Chronic ongoing nerve pain including neck, back, legs, arms.   Treated with anti-inflammatory ibuprofen.  Adverse effects have continued to this day. I?m concerned about permanent damage or continuing inflammation.  (First vaccination produced 4 days of discomfort as well although different effects; malaise, general flu symptoms.
States developed "palm sized red bumpy" rash on mid abdomen within 24 hours post administration of second JE Vax vaccine, associated with itching. No respiratory involvement. No reaction after first JE Vax. Self treated with aloe vera. Did not see doctor.
Pfizer 3/1/21, 3/22/21, 12/14/21. Postitive on 6/2/22
sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore left injection site arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included ADENOSINE from 03-Sep-2021 to an unknown date for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (sore left injection site arm). At the time of the report, MYALGIA (sore left injection site arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate increased: high (High) Heart rate elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's consent to follow-up was affirmative.  Treatment product information was not provided.   This case was linked to MOD-2021-311047, MOD-2021-311053 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Follow up received no new information.
Patient has not contacted us. Daughter states that "shot was given too high and her arm has not been right since". Patient did seek medical treatment.
After the 2nd dose, her immune system was determined weak; she had cuts inside her mouth; This is a spontaneous report from a Pfizer sponsored program. This was a report combining information from duplicate reports 2021523522 and 2021530750. The current and all subsequent information will be reported under manufacturer report number 2021530750. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration on 05May2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 for covid-19 immunisation, sulfamethoxazole, acyclovir [aciclovir sodium]. Historical vaccine information included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) 1st dose on 14JApr2021 for COVID-19 Immunization. The patient experienced after the 2nd dose, her immune system was determined weak, and she had cuts inside her mouth on May2021. It was reported that Caller had her 2nd dose of Pfizer Covid-19 vaccine last 5May2021 and her doctor prescribed an antibiotic to her. After the 2nd dose, her immune system was determined weak, and she had cuts inside her mouth. She was calling to know when she can start taking the antibiotic because her doctor told her that it might affect the vaccine. Her 1st dose was given 14Apr2021. Her doctor prescribed two medications before she received the Pfizer Covid 19 vaccine. Medications were an antibiotic (sulfamethoxazole) and acyclovir. The outcome for all events were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Hair dye allergy suddenly developed after Covid booster. Allergic reaction to dye containing PPD which caused contact dermatitis and swelling of the face. Also developed constant ringing in the ears (tinnitus) which wasn't there prior to Covid vaccination.
Stated he felt nausea, tiredness, general weakness, headache, loose stools at time of onset. To treat he took OTC ibuprofen. Symptoms reduced in severity over the next three days, and remained the same for about one week. On the 28th symptoms worsened and now include loss of appetite, chills, and more pronounced weakness. Stated he has not made an appointment with a health care provider yet. Also has had several brief encounters with people exhibiting mild sickness due to employment in a customer service job.
tachycardia; dizziness; throat swelling; blotches on chest; palpitations; chest tightness/had residual mild chest discomfort and noticed 2 blotches on chest in car; metallic taste in mouth; This is a spontaneous report from a contactable physician (patient). A 33-year-old female patient received the 1st dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899) via Intramuscular on 28Dec2020 12:30 PM at single dose in the arm left for COVID-19 immunisation. Medical history included Bee venom (anaphylaxis), hereditary fructose intolerance (HFI, HFI as above but no previous issues with sucrose containing vaccines) and Known allergies: Bee venom (anaphylaxis). Concomitant medications included Linaclotide, Adderall, polyethylene glycol 3350. Roughly 5-7 minutes after injection, the patient experienced palpitations, chest tightness, and metallic taste in mouth - sensations mostly subsided after another 5 minutes so did not report. Left center after 30 mins, the patient had residual mild chest discomfort and noticed 2 blotches on chest in car. Drove home - on the way at 13: 15 (45 mins post vaccine), developed throat swelling, severe chest tightness, tachycardia (HR 130s), and dizziness. Severe symptoms (throat swelling particularly) subsided after 5 minutes but other symptoms persisted for another hour. Used albuterol, had epi pen ready but didn't use. Now 3 hours out, feeling close to baseline. The patient underwent lab tests, which included Covid test post vaccination with Negative result in Dec2020. The patient received treatment for events, which included Albuterol. Outcome of events was recovering.
Minor presented with congestion, itching and rash to neck and arms 1-2 hours after administration of 1st series vaccines.